KISS1R and ovarian hyperstimulation syndrome: Kisspeptin’s ability to prevent the onset of OHSS seems to be due to its short duration of action, and it is hypothesized that its direct action on ovarian KISS1R inhibits VEGF secretion, thereby reducing the incidence of OHSS [70,92].